CAR T-CELL
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
CAR T-CELL
Jun 18, 2024, 14:43 |
Immune Oncology
CAR T Cell Therapy for Cancer Treatment
Introduction Chimeric antigen receptor - CAR T Cell therapy represents a groundbreaking approach in cancer…
Jun 11, 2024, 14:59 |
Insight
Timos Papagatsias: EHA24 is expected to be one of the most exciting EHA conferences to-date!
Timos Papagatsias, CEO of LucidQuest shared a post on LinkedIn: “EHA24 is fast approaching and…
May 26, 2024, 11:34 |
Insight
Krishna Komanduri: Congrats to Sattva Neelapu and colleagues for this correlative study on CAR-T cell fitness and function in lymphoma
Krishna Komanduri, Physician-in-Chief at the Helen Diller Family Comprehensive Cancer Center, shared a post by…
Apr 15, 2024, 02:29 |
Insight
Evan Weber: Transcription factors that drive beneficial memory programs in CAR T cells
Evan Weber, Assistant Professor of Pediatrics at the University of Pennsylvania Perelman School of Medicine,…
Feb 21, 2024, 18:18 |
Insight
Vivek Subbiah: As of December 31, 2023, the FDA had become aware of 22 cases of T-cell cancers that occurred after treatment with CAR-T products
Vivek Subbiah shared on LinkedIn: "Perspective article on 'Secondary Cancers after Chimeric Antigen Receptor T-Cell…
Feb 2, 2024, 05:57 |
Blog
Mark Geyer: Tigen Pharma has formally agreed to partner with us in clinical development of our CAR T-cell product for AML
Mark Geyer, Assistant Attending Physician at Memorial Sloan Kettering Cancer Center, recently shared on X/Twitter:…
Jan 19, 2024, 17:40 |
Opinion
Nishant Tiwari: Educational thread on hemophagocytic lymphohistiocytosis
Nishant Tiwari, Incoming Hematology-Oncology Fellow at OU Health Stephenson Cancer Centre, shared a thread on…
Jan 8, 2024, 15:01 |
Blog
Li Tang: We discovered that IL-10-expressing CAR T-cells resist T cell dysfunction and mediate durable clearance of solid tumors and metastases
Li Tang, Associate Professor at the Swiss Federal Institute of Technology Lausanne (EPFL), shared a…
Nov 17, 2023, 17:20 |
Blog
Giles Robinson: Loc3Car is the St. Jude Children’s Research Hospital's Brain Tumor Program’s first venture into Car T-Cell therapy
Giles Robinson, Neuro-Oncology Division Director at St. Jude Children’s Research Hospital, shared on X/Twitter: "Loc3Car…
Sep 25, 2023, 16:24 |
Blog
Graham Collins: Reflections on being a new National Health Service (NHS) CAR T-cell centre.
Quoting Graham Collins, Associate Professor of Hematology at the Oxford Cancer and Hematology Center, on…
1
2
All:
11
Posts:
1 - 10
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
15 Posts You Should Not Miss From The 1st Day of ESMOGI24
Facebook
RSS Feed
Twitter
Linkedin
Youtube